Santhera Pharmaceuticals Holding AG (OTCMKTS:SPHDF) Short Interest Update

Santhera Pharmaceuticals Holding AG (OTCMKTS:SPHDF) was the target of a large growth in short interest in the month of December. As of December 31st, there was short interest totalling 1,200 shares, a growth of 50.0% from the December 15th total of 800 shares. Based on an average daily volume of 200 shares, the short-interest ratio is currently 6.0 days.

Santhera Pharmaceuticals Stock Performance

Shares of Santhera Pharmaceuticals stock remained flat at $9.42 on Thursday. The business has a 50-day moving average price of $10.29 and a 200-day moving average price of $11.21. Santhera Pharmaceuticals has a 52 week low of $9.42 and a 52 week high of $9.42.

About Santhera Pharmaceuticals

Santhera Pharmaceuticals Holding AG, a specialty pharmaceutical company, together with its subsidiaries, develops and commercializes medicines for rare neuromuscular and pulmonary diseases with high unmet medical need in the European Union and internationally. The company's lead pipeline candidate includes Vamorolone, which is being developed for the treatments of Duchenne muscular dystrophy (DMD).